Rockwell Medical (RMTI) Cash & Equivalents (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Cash & Equivalents came in at $9.6 million in Q1 2026, down 15.64% YoY from $11.4 million in Q1 2025, and down 10.29% on a QoQ basis from $10.7 million in Q4 2025.
Rockwell Medical (RMTI) Cash & Equivalents (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Cash & Equivalents data on file, last reported at $9.6 million in Q1 2026.
- Quarterly Cash & Equivalents fell 15.64% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (down 15.64% YoY) and the FY2025 annual result came in at $10.7 million, down 31.61% from the prior year.
- Cash & Equivalents eased to $9.6 million in Q1 2026, from $10.7 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $30.8 million in Q2 2022 to a low of $6.6 million in Q1 2024.
- A 5-year average of $12.0 million and a median of $10.9 million in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 72.25% — and 2024, when it jumped 74.35%.
- Tracing RMTI's Cash & Equivalents over 5 years: stood at $10.1 million in 2022, then decreased by 11.08% to $9.0 million in 2023, then soared by 74.35% to $15.7 million in 2024, then slumped by 31.61% to $10.7 million in 2025, then dropped by 10.29% to $9.6 million in 2026.
- The last three Cash & Equivalents figures came in at $9.6 million (Q1 2026), $10.7 million (Q4 2025), and $13.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 10.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.52 Mn |
| Mar 31, 2026 | 9.61 Mn |
| Dec 31, 2025 | 10.71 Mn |
| Sep 30, 2025 | 13.61 Mn |
| Jun 30, 2025 | 12.48 Mn |
| Mar 31, 2025 | 11.39 Mn |
| Dec 31, 2024 | 15.66 Mn |
| Sep 30, 2024 | 12.34 Mn |
| Jun 30, 2024 | 11.86 Mn |
| Mar 31, 2024 | 6.64 Mn |
| Dec 31, 2023 | 8.98 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 8.96 Mn |
| Mar 31, 2023 | 10.89 Mn |
| Dec 31, 2022 | 10.10 Mn |
| Sep 30, 2022 | 12.98 Mn |
| Jun 30, 2022 | 30.78 Mn |
| Mar 31, 2022 | 9.90 Mn |
| Dec 31, 2021 | 13.28 Mn |
| Sep 30, 2021 | 23.39 Mn |